NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 200 filers reported holding NEKTAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $32,351,000 | -28.4% | 1,950 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $45,162,000 | +23.5% | 1,950 | +225.0% | 0.01% | +40.0% |
| Q3 2018 | $36,576,000 | +66.5% | 600 | +33.3% | 0.01% | +66.7% |
| Q2 2018 | $21,974,000 | -54.0% | 450 | 0.0% | 0.01% | -57.1% |
| Q1 2018 | $47,817,000 | +77.9% | 450 | 0.0% | 0.01% | +100.0% |
| Q4 2017 | $26,874,000 | -65.5% | 450 | -86.2% | 0.01% | -65.0% |
| Q3 2017 | $78,000,000 | +22.8% | 3,250 | 0.0% | 0.02% | +53.8% |
| Q2 2017 | $63,538,000 | -12.7% | 3,250 | +4.8% | 0.01% | -7.1% |
| Q1 2017 | $72,757,000 | -27.0% | 3,100 | -55.7% | 0.01% | -17.6% |
| Q2 2016 | $99,610,000 | -57.9% | 7,000 | -59.3% | 0.02% | -61.4% |
| Q1 2016 | $236,500,000 | -18.4% | 17,200 | 0.0% | 0.04% | -12.0% |
| Q4 2015 | $289,820,000 | – | 17,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |